HERPES ZOSTER INFECTION IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING TOFACITINIB: RESULTS FROM THE PHASE 2 AND PHASE 3 CLINICAL PROGRAMMES

Kevin L. Winthrop  ¹     Gil Y. Melmed  ²     Severine Vermeire  ³     Julian Panés  ⁴     nicole kulisek  ⁵     Rajiv Mundayat  ⁶     Nervin Lawendy  ⁶     Chinyu Su  ^6    
1 Oregon Health & Science University, Portland, United States
² Cedars-Sinai Medical Center, Los Angeles, United States
³ University Hospitals Leuven, Leuven, Belgium
⁴ Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
⁵ Pfizer Inc, Collegeville, United States
⁶ Pfizer Inc, New York, United States

Topic
IBD

Session
Safety and outcomes of interventions in IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)